STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1032 participants.

Also called NCT07007143

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 1,032 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07007143
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07007143. Randomized; no masking; primary purpose treatment. Start 2025-07-31 (actual); primary completion 2028-09-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant
Acronym
STAR-TEER Ⅱ
Condition
Mitral Regurgitation
Intervention (Drug)
Experimental: Aspirin monotherapy
Intervention (Drug)
Active Comparator: Aspirin+Clopidogrel
Lead sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)

Record details

Record id
cardio:ct-nct07007143
Content hash
ebff7a02d48d691069c03665c0a1bcea2827d47b99c7cc3427984ba7c14588a5